Blueprint Medicines Corporation Profile Avatar - Palmy Investing

Blueprint Medicines Corporation

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (S…
Biotechnology
US, Cambridge [HQ]
Strategy & Leadership

Qualitative Analysis

Business

Framework: SWOT 7's
End of BPMC's Analysis
CIK: 1597264 CUSIP: 09627Y109 ISIN: US09627Y1091 LEI: - UEI: -
Secondary Listings
BPMC has no secondary listings inside our databases.